- Consumer Products
- Latest 134.595
- Currency US$
- Change 2.515
- Percent Change 1.904 %
- Volume 546,794
- Thu Oct 30, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jul 31||$-0.20||Nov 4||$0.36|
12 months ended Oct 31, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.
Head OfficePHARMACYCLICS INC 995 E ARQUES